Correction of patient results for Beckman Coulter LX-20 assays affected by interference due to hemoglobin, bilirubin or lipids: A practical approach

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 1, 2007, Pages 114-119

  Vermeer, Henricus J ^a   Steen, Gerard ^b   Naus, André J M ^c   Goevaerts, Berrie ^d   Agricola, Pauline T ^d   Schoenmakers, Christian H H ^e  

^a Ziekenhuis Hilversum   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c LAURENTIUS HOSPITAL   (Netherlands)

^d BECKMAN COULTER INC   (United States)

^e ELKERLIEK HOSPITAL   (Netherlands)

Author keywords

Clinically significant interference; Hemolysis; Icterus; Lipemia; Synchon LX 20

Indexed keywords

BILIRUBIN; C REACTIVE PROTEIN; CHOLESTEROL; CREATINE KINASE MB; FERROCYANIDE; HAPTOGLOBIN; HEMOGLOBIN; IRON; LACTATE DEHYDROGENASE; LIPID; POLYMER; POTASSIUM;

ALGORITHM; ANALYZER; ARTICLE; BECKMAN COULTER; CENTRIFUGATION; CLINICAL LABORATORY; DILUTION; HEMOGLOBIN ANALYSIS; HUMAN; HYPERLIPIDEMIA; IN VIVO STUDY; INTRAVASCULAR HEMOLYSIS; JAUNDICE; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; SAMPLE;

BILIRUBIN; BIOLOGICAL ASSAY; BLOOD CHEMICAL ANALYSIS; HEMOGLOBINS; HEMOLYSIS; HUMANS; HYPERLIPIDEMIAS; JAUNDICE; LIPIDS; REPRODUCIBILITY OF RESULTS;

EID: 33846528579     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2007.004     Document Type: Article

References (21)

1. Young DS. Effect of drugs on clinical laboratory tests. Washington, DC: AACC, 1990.
2. Andall AG, Garcia-Webb P, Beilby JP. Interference by haemolysis, icterus and lipaemia in assays on the Beckman Synchron CX5 and methods for correction. Ann Clin Biochem 1990;27:345-52.
3. Steen G, Vermeer HJ, Naus AJ, Goevaerts B, Agricola PT, Schoenmakers CH. Multicenter evaluation of the interference of hemoglobin, bilirubin and lipids on Synchron LX-20 assays. Clin Chem lab Med 2006;44:413-9.
4. Kroll MH, Elin RJ. Interferences with clinical laboratory analyses. Clin Chem 1994;40:1996-2005.
5. Sheppard CA, Allen RC, Austin GE, Young AN, Ribeiro MA, Fantz CR. Paraprotein interference in automated chemistry analyzers. Clin Chem 2005;51:1077-8.
6. Behrendt H. Chemistry of erythrocytes. Springfield, IL: Charles C Thomas, 1957.
7. Caraway WT. Chemical and diagnostic specificity of laboratory tests. Am J Clin Pathol 1962;37:445-64.
8. Sonntag O, Glick MR. Serum-Index und Interferogramm - ein neuer Weg zur Prüfung und Darstellung von Interferenzen durch Serumchromogene. Lab Med 1989;13:77-81.
9. Schoenmakers CH, Kuller T, Lindemans J, Blijenberg BG. Automated enzymatic methods for creatinine measurement with special attention to bilirubin interference. Eur J Clin Chem Clin Biochem 1993;31:861-8.
10. Spain MA, Wu AH. Bilirubin interference with determination of uric acid, cholesterol, and triglycerides in commercial peroxidase-coupled assays, and the effect of ferrocyanide. Clin Chem 1986;32:518-21.
11. Lippi G, Salvagno, GL, Montagnana M, Brocco G, Guidi GC. Influence of hemolysis on routine clinical chemistry testing. Clin Chem Lab Med 2006;44:311-6.
12. Ismail A, Shingler W, Seneviratne J, Burrows G. In vitro and in vivo haemolysis and potassium measurement. Br Med J 2005;330:949.
13. Jay DW, Provasek D. Characterization and mathematical correction of hemolysis interference in selected Hitachi 717 assays. Clin Chem 1993;39:1804-10.
14. Dimeski G, Clague AE, Hickman PE. Correction and reporting of potassium results in haemolysed samples. Ann Clin Biochem 2005;42:119-23.
15. Hawkins R. Variability in potassium/hemoglobin ratios for hemolysis correction wletterx. Clin Chem 2002;48:796.
16. Manoharan A. Congenital haptoglobin deficiency. Blood 1997;90:1709
17. Vassault A, Grafmeyer D, Naudin C, Dumont G, Bailly M, Henny J, et al. Protocol for the validation of methods. Document B, stage 3. Commission for validation of methods of the Sociéteacute; Francaise de Biologie Clinique. Ann Biol Clin 1986;44:686-745.
18. Westgard JO. Desirable specifications for total error, imprecision, and bias, derived from biologic variation. http://www.westgard.com/biodatabase1.htm.
19. Sigurdsson G. Enteral or parenteral nutrition? Proenteral Acta Anaesthesiol Scand Suppl 1997;110:143-7.
20. Chong PH, Bachenheimer BS. Current, new and future treatments in dyslipidaemia and atherosclerosis. Drugs 2000;60:55-93.
21. Bornhorst JA, Roberts RF, Roberts WL. Assay-specific differences in lipemic interference in native and Intralipid-supplemented samples. Clin Chem 2004;50:2197-201.